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Los Angeles, Cal$ornia 
hormone metabolism own to nor- 
mal in nonthyroidal illness manifested by low triiodot~yro- 
nine (T3), elevated reverse T, and normal thyroid- 
stimulating hormone (1). Thyroxine (T,) !eveils can be 
normal, elevated or reduced (2) and in patients ko 
in medical intensive care units, low thyroxine 
associated with a high mortality rate (3). 
investigating thyroid function in nonthyroid illnesses have 
combined patients with a variety of illnesses and have not 
differentiated among the underlying diseases or compared 
patients with various degrees of severity of one illness. 
Levels of Ts are known to be low during acute myocardial 
infarction (6,7) and cardiac arrest (8), but the prevalence and 
significance of abnormal thyroid metabolism in chronic 
congestive heart failure have not yet been determined. 
Therefore, we analyzed thyroid hormone levels in relation to 
hemodynamics, nutritional status and survival in a large 
cohort of patients with advanced heart failure. 
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St ur study group consisted of 84 consec- 
utive nts admitted to the coronary care unit for evalu- 
ation and treatment of advanced congestive heart failure, 
frequently in conjunction with evaluation for cardiac trans- 
plantation. An additional seven patients taking amiodarone, 
four patients with clinical hypothyroidism and one patient 
with ~y~erthyroidism were not included. The study group 
consisted of 70 men and 14 women, aged 17 to 71 years 
(mean 50), of whom 38 had ischemic, 24 idiopathic, I5 
valvular. 5 alcoholic and 2 postpartum cardiomyopathy. 
These patients had an average left ventricular ejection 
fraction determined by two-dimensional echocardiography 
of 18 2 5% and severe congestive symptoms despite previ- 
ous medical therapy. No patient was receiving a beta- 
adrenergic blocking agent, steroids, aspirin, heparin or Di- 
lantin (phenytoin sodium) (medications known to alter 
thyroid metabolism) (9-11) and none had received radio- 
graphic contrast medium within 2 weeks before measure- 
ment of thyroid hormone levels (12). Six patients were 
receiving intravenous dopamine at the time of transfer, but 
none had received any intravenous inotropic infusion for 
>48 h. 
Study protocol. On the day of right heart catheterization, 
venous blood samples were obtained for measurement of 
electrolytes, bilirubin. serum glutamic oxaloacetic transam- 
inase (SGOT), creatinine, thyroid-stimulating hormone 
(Celltech Diagnostics, normal 0.4 to 4.4 mu/liter, coeffi- 
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cients of variability: intraassay 5.5%, interassay 5.2%) (1% 
reveme T3 (Serono-Baker Diagnostics, normal 5 to 29 @ml, 
intmssay 6%, interassay 9%) (14), T4 (Organon Teknika, 
normal 5to 11 clgldl, intraassay 7.4%, interassay 5.9%) (15) 
and T3 (Organon Teknika, normal 75 to 175 ngldl, intraassay 
9.6%, interassay 11%) (16). In this study, we used the free T4 
index and free T3 index to correct for variations in serum- 
binding protein levels. These indexes are the product of the 
total serum hormone level and the amount of labeled hor- 
mone that binds to resin after being incubated with the 
patient’s serum (17). 
Total lymphocyte count, serum albumin and percent 
body fat (calculated from triceps, chest, supraileal nd thigh 
skinfold thickness) (18) were also measured as indexes of 
nutritional status. A pulmonary artery flotation catheter was 
passed under fluoroscopic guidance and baseline hemody- 
namic measurements were obtained after a 2 h equilibration 
period. Cardiac output was determined as the average of 
three values obtained by the thermodilution technique. 
Because nonthyroid illness is associated with both a 
decrease infree TJ index and an increase inreverse T3, the 
free Ts index/reverse Ts ratio was evaluated as a potentially 
sensitive index of metabolic derangement. A free Ts index/ 
reverse T3 ratio of 4 was chosen to divide the study cohort 
into two groups because it represented the midpoint in the 
range of values (0 to 8) displayed by 95% of the patients, as 
well as the lower limit of normal as calculated from our 
laboratory normal values: (free T3 index mean - 1 SD)/ 
(reverse T3 mean + 1 SD). Therefore, the patients were 
classified into two groups-free T3 index/reverse T, ratio >4 
(35 patients) and free TJ index/reverse T3 ratio 54 (49 
patients)-for comparative analysis of hemodynamics, ejec- 
tion fraction, nutritional variables, hepatic and renal func- 
tion, serum sodium and survival. 
During hospitalization, all patients received intravenous 
afterload reduction therapy followed by institution of high 
dose oral vasodilating and diuretic drugs. Clinically stable 
patients were discharged on this regimen. Those with hemo- 
dynamic instability requiring continued inotropic support, 
intraaortic balloon counterpulsation r a left ventricular 
assist device were placed on the urgent cardiac transplanta- 
tion list if they were eligible. Because this outcome reflects a 
dismal prognosis without ransplantation, it was included 
along with death as the “poor outcome” end point. Outpa- 
tients awaiting elective heart ransplantation were not con- 
sidered with this group because the degree of illness in all of 
the study patients was severe nough to warrant transplan- 
tation if they were eligible (19) and we have shown the 
functional and hemodynamic status in the group with elec- 
tive transplantation to be similar to that of the patients 
followed uP on medical therapy and not accepted for trans- 
Plantation (20). In addition, the average outpatient waiting 
Period is >3 months, during which time the mortality rate is 
highest, so that those surviving to elective transplantation 
Table 1. Relation of Free T, Index/Reverse T, Ratio to 
Hemodynamics and Ventricular Function 
Free TJ Index/ 
Reverse T, Ratio 
Ejection fixlion (%‘o) 
Cardiac index (liters/min m’) per 
Right atrial pressure (mm Hg) 
Mean pulmonary artery pressure (mm Hg) 
Pulmonary wedge pressure (mm HE) 
54 >4 
16 2 5 19 !I 5* 
1.8 f 0.6 2.1 + 0.6* 
I5 t 6 10 + 6* 
39 f 10 33 f 13* 
29 + 8 23 f lO* 
*p c 0.05. Data are expressed as mean values f SD. 
reflect a better prognostic group than those who died or 
required urgent transplantation. 
Data analysis. The normal (>4) and low (54) free T3 
index/reverse T, ratio groups were compared by using 
two-tailed Student’s t tests. Univariate and multivariate 
regression analyses were performed with a BMDP statistical 
package (21) to assess the relative predictive value for poor 
6 week outcome of measured hemodynamic values, serum 
sodium and thyroid function abnormalities. The 12 month 
actuarial survival rate was calculated with placement on the 
urgent ransplantation listconsidered as death and elective 
transplantation c sidered tobe the last day of the follow-up 
period. The actuarial survival curves were compared with 
the use of Breslow and antel-Cox statistical nalyses. 
Thyroid function tests. Serum free T4 index was normal 
in all 84 patients. Free Ts index was low in 24 patients and 
reverse T3 elevated in3 1 patients. The free T3 index/reverse 
T3 ratio was ~4 in 49 patients (58%). A slight increase in 
thyroid-stimulating hormone between 5 and 10 mU/liter was 
present in four patients (a value >15 mu/liter is believed to 
be present in patients with clinical and biochemical evidence 
of hypothyroidism) (2 . 
Comparison with hemodynamics, chemistry values and 
nutritional status. Comparisons of the normal and low free 
T3 index/reverse Tj ratio groups revealed that a ratio ~4 was 
associated with a lower ejection fraction and cardiac index 
and a higher ight atria1 pressure, mean pulmonary artery 
pressure and pulmonary capillary wedge pressure (Table 1). 
Serum sodium was lower and bilirubin, SGOT and creatinine 
higher in the low ratio group, but free T4 index and thyroid- 
stimulating hormone were similar in both groups (Table 2). 
The mean total ymphocyte count and serum albumin in the 
patients with a low free T3 index/reverse T, ratio were below 
the normal range, significantly ower than in those with a 
normal ratio. There was no difference in percent body fat. 
The mean duration of symptoms before referral was 34 
months in both groups. 
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elation of Free T3 Index/Reverse T3 
Values and Nutritional Variables 
Free T, Index/Reverse T, 
54 >4 
Free T4 index (5-l 1) 7.0 2 2.8 8.0 + 3.1 
Free TS index (75175) 7s f 21” 117 f 22 
Reverse TS (5-29 nglnl) 36 rL IS’ 21 27 
3.4 2 2.7 2.5 + 1.5 
Serum sodium (136-146 mmollliter) 133 + .5* 138 2 4 
SGOT (S-40 U/liter) 56 -c 87* 24 r 10 
Bilimbin (0.3-1.2 mgldl) 1.8 -+ 1.3* I.0 r 0.6 
Creatinine (0.7-1.3 mg/dl) 1.3 + 0.4* I.1 + 0.2 
Albumin (4.0-5.2 g/dl) 3.8 2 0.5* 4.2 t 0.4 
Total lymphocyte count ~~l,5tM/cm3~ 1,358 + 577* 1,414 + 642 
% body fat (IO%22%) 15.4 2 6.6 17.9 t 6.4 
*p < 0.05. Data are expressed as mean values + SD. Numbers in 
parentheses r 
transaminase; 
0 normal values. SGOT = serum glutamic oxaloacetic 
= thyroid-stimulating hormone. 
e. During the initial ~~s~ita~~zation, 8 patients 
(10%) died and 6 (7%) were placed on the urgent tra 
tation list; the condition of 70 patients (83%) was st 
and they were discharged onoral medications. There were a 
total of 23 “poor outcomes” (17 deaths and 
plantations) in the 84 patients within I year after initial 
referral; 14 of these outcomes occurred before hospital 
discharge. Elective cardiac transplantation was pe 
15 patients after a waiting period of 3.3 2 3.2 mo 
patients were not included in the poor outcome group 
because of the clinical similarity of patients undergoing 
transplantation electively and those remaining on medical 
therapy after referral for transplantation (20), as mentioned 
previously. The average l ngth of follow-up study in patients 
without ransplantation or death was 7.3 f 6.6 months. 
Low free T3 index, high reverse T,, low fPee T3 index1 
reverse T3 ratio and high right atria1 pressure were each 
univariate predictors of poor outcome (death within 6 weeks 
or placement on the urgent transplantation list) (p < 0.01). 
Serum sodium was of borderline univariate significance (p = 
0.08). In multivariate r gression analysis, however, the free 
T, index/reverse T, ratio was the only independent prognos- 
tic indicator (p < 0.001). No patient with a free T, index/ 
reverse T3 ratio >4 died or required urgent transplantation n 
the follow-up eriod, leading to a predicted 1 year survival 
rate of 100%. The actuarial survival rate in the group with a 
free T, index/reverse T3 ratio 54 was 37% at 12 months (Fig. 
l), with 76% of the deaths and all of the urgent transplanta- 
tions occurring within the first 6 weeks of referral. Further 
analysis of free T3 index/reverse T3ratio groups revealed 
that even within the high risk group, the lowest free T3 
index/reverse TS ratios were associated with the poorest 
prognoses during this 6 week period (Fig. 2). 
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e) and abnormal (~4) in 49 
normal ratio group died or 
underwent urgent cardiac t~a~s~~antatiou during this period. ~~~o~s 
indicate the number of patients followed up over each time interval. 
re. In this study, we have 
tabolism is frequently al- 
heart failure. The most 
tudied was a reduction 
in free T3 index or an increase inreverse T,, or both, leadi 
to a low free T3 index/reverse T, ratio in ~50% of t 
patients. Free Td inde was normal in all patients studi 
suggesting that he me anism involved is different from that 
found in severely ill patients in a general medical intensive 
care unit (3); in that group, Td was found to be low in 22% 
and was the only thyroid test associated with a poor prog- 
Figure 2. Short-term outcome in 84 patients with heart failure. Poor 
outcome includes death or urgent transplantation within 6 weeks 
after referral. Data in parentheses represent the number of patients 
with a poor outcome in each group. Logistic regression analysis 
revealed the free T, index/reverse TX ratio to be highly predictive of 
outcome (p < 0.0001). 
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nosis. &spite the low free T3 index in our patients, thyroid- 
stimulating hormone was normal in 95% and only mildly 
elevated in the others, g finding consistent with previous 
reports (2). The degree of T3 abnormality was clearly related 
to the hemodynamic severity of illness because the ejection 
fraction and ah hem~yn~ic variables were significantly 
worse in the patients with a low free T, inde~reverse Ts
ratio. However, thyroid function was not related to the 
duration of illness. 
pOtenthtl m~hanisms for alterations in thyroid hormone 
metahelism, The mechanism by which thyroid hormone 
meta~lism isaltered in nonthyroid llness is not known. The 
reduction i free Ts index and increase in reverse T3 levels 
are most likely due to an inhibition of iodothyronine 5’- 
deiodinase, the enzyme that both converts T4 to Ts and leads 
to reverse Ts catabolism (22). There is evidence to support 
the existence of a thyroid-binding inhibitor that alters the 
avail~iIity of Tg for metabolism and inhibits i~othyronine 
S-deiodinase (1 I), an enzyme located primarily in mi- 
crosomes ofliver and kidney (23). Impaired enzyme function 
is the suggested mechanism underlying similar thyroid hor- 
mone abnormalities found in patients with hepatic irrhosis 
(24). 
Our finding that SGOT and bilirubin concent~tions were 
higher in the patients with a low free T, index/reverse T3
ratio supports the hypothesis that impairment of hepatic 
function secondary to passive congestion i these patients 
may reduce the iodothy~nine 5’-deiodinase activity and 
consequently lead to low free T3 index and high reverse T3. 
However, because Tj production isknown to be reduced in 
the fasting state (25,26), poor nutritional status may also 
contribute to altered thyroid metabolism in chronic heart 
failure. This is supported by our finding that serum albumin 
and total ]ymphocyte count, indicators ofnut~tiona] status, 
were lower in patients with a low free T3 index/reverse T3
ratio than in those with normal T3 metabolism. However, 
total body fat was not reduced, suggesting that the patients 
were not severely mahtouri&d. 
prognostic importgnce of abnormal thyroid knrmone l v- 
*. In previous reports (27,28), elevated right atria1 pressure 
and IoW serum sodium have been identified as indicators of
poor prognosis npatients with congestive heart failure. In 
this study, however, alow free T:, index/reverse T, ratio was 
shown to be a more significant prognostic factor than any 
hem~yn~ic or electrolyte variable and in fact was the only 
inde~ndent predictor of shod-tea mortality. In patients 
with cin-hosis, free T3 index/reverse T3 ratio predicted death 
only ifit was IO-fold lower than normal (29) whereas in our 
Patients with heart failure, any reduction i  this ratio below 
the normal range was associated with a poor prognosis. 
W ~~~ti~ in ~~ ~a~~ bairn 
in krt fake. It is possible that the thyroid function 
abnormalities n these patients with heart failure predict poor 
outcome gtl%tly as an indicator of severe disease, in which 
the low conversion to Ts may be an adaptive mecba~ism to 
reduce catabolism. Conversely, the low TX levels could 
contribute to the severity of illness. Hypothyroidism is
known to impair the intrinsic ontractile state of the myo- 
cardium (30), which could accelerate he dete~oratio~ f 
vent~cular function. Hy~thyroidism can also cause atrio- 
ven~cular block (31) or proIong the vent~cMl~r refractor 
period and the dispersion of refractoriness (32), possibly 
predisposing patients to lethal arrhythmias. In addition, 
hypothyroidism inhibits the release of atria1 natriuretic fac- 
tor, a cardiac hormone that hdps counteract the 
tion in heart failure (33). Because thy~id hormone modula- 
tion of myocardial cell function is believed to occur tbroMgh 
specific T, nuclear receptors (34), it is possible that even in 
patients who appear “euthyroid” by T4 and thyroid- 
stimulating hormone criteria, low T3 could exacerbate h art 
failure by these mechanisms and cont~bute to the poor 
prognosis. 
Conclusions. This study demonstrates that thyroid hor- 
mone metabolism is frequently altered in patients with 
advanced heart failure in a different manner than has been 
previously described for other severe noothyro~da~ illnesses; 
free T4 index levels are preserved, but the free TX index is 
often low and reverse TJ high. Although an abnorma] free Tj 
index/reverse 1; ratio is associated with lower ejection 
fraction, higher filling pressures, lower serum sodium and 
worse nutritional status, this ratio is the strongest predictor 
yet identified for short-term o~&come in patients with severe 
heart failure. 
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